Pfizer (PFE) Tops Q4 EPS by 1c

Pfizer (NYSE: PFE) reported Q4 EPS of $0.53, $0.01 better than the analyst estimate of $0.52. Revenue for the quarter came in at $14.05 billion versus the consensus estimate of $13.57 billion.

Guidance:

The Company sees FY16 EPS of $2.20 - $2.30 and revenue of $49 - $51 billion. The Street is looking for EPS of $2.36 and revenue of $52.5 billion.

For earnings history and earnings-related data on Pfizer (PFE) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Enovix Corporation (ENVX) PT Lowered to $5 at BofA Securities